News Locations
EN | FR
Practices
People
Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Inclusion Pro Bono
Practices
People
Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Inclusion Pro Bono
News Locations
EN | FR
Practices
People
News
View All Results >

Patrice Jean

New York City

+1 (212) 837-6264

[email protected]
Download V Card
Share/Print
Email Print
   
Biography
Selected Matters
Client Advisories
News

Patrice P. Jean is Chair of Hughes Hubbard’s Life Sciences group. She has over a decade of experience counseling leading and startup pharmaceutical, chemical and biotechnology companies in all areas of intellectual property law. In particular, she is adept at asserting and defending the patent rights underlying the core technologies and innovations of leading high-tech and pharmaceutical companies. She also defends her clients against claims asserted by competitors, sparing them billions of dollars in damages. Additionally, her patent trademark prosecution practice strengthens her litigation abilities, allowing her to argue the validity of her clients’ IP while challenging the validity of third-party registrations. Patrice regularly calls on her technical background in biology to offer her clients an in-depth understanding of the complex science relative to each prosecution and litigation matter that she handles. This vantage point leaves her well-positioned to understand the complex science behind her clients’ innovations as well as the broader market implications. Prior to law school, Patrice earned her Ph.D. in molecular biology. She conducted research in various areas of biology and biochemistry including virology, oncology, kidney disease, X-ray crystallography and narcotics addiction. Her doctoral thesis is titled “Tissue, Strain, Gender and Age Variation in the Induction of p53 Activated Transcripts in Response to Cellular Stress.”

Professional Activities

  • President, New York Intellectual Property Law Association (2024 – 2025)
  • Vice President, New York Intellectual Property Law Education Foundation
  • Executive Committee member, William C. Conner Inn of Court
  • Board of Directors member, Relief Therapeutics (June 2021-April 2024)
  • Member, National Bar Association, Treasurer, Intellectual Property Section (2018-2019)
  • Leadership Council on Legal Diversity; 2014 fellow and past chair of the Working Group on Contribution Communications for the “All In” Campaign

Recognition

  • Named to Managing IP’s “IP Stars” list as a Patent Star, Trademark Star (2023, 2024)
  • Named to IAM Patent 1000’s “The World’s Leading Patent Professionals” list (2018-2024)
  • Named to Savoy Magazine’s “Most Influential Black Lawyers” list (2022, 2024)
  • Named HBCU Greatness’ 1st Annual Holiday Gala Sneaker Ball Honoree (2023)
  • Named to Profiles in Diversity Journal’s “Women Worth Watching” list (2020)

Previous Experience

  • Partner, Kenyon & Kenyon, 2012 – 2015

Highlighted Publications

  • “Patent Thicket Concerns Have Started Something Brewing at the Patent Office: Are Extensive Changes to Patent Practice on the Horizon?,” (January 2023)
  • "Skilled in the Art: A Reply to Senators’ ‘Thicket’ Concerns," Law.com (June 24, 2022)
  • "IP and COVID-19," Pharmaceutical Executive (March 11, 2021)
  • "Estate Planning for the Digital Afterlife," New York Law Journal (Nov. 10, 2016)
  • "Protecting Life Science Inventions in View of the USPTO's 'Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Law of Nature, Natural Phenomena and Natural Products,'" Bloomberg BNA: Life Sciences Law & Industry Report (April 4, 2014)
  • "A Year of Changes for Life Sciences IP," Law360 (Dec. 18, 2013)
  • "Myriad: Practice Points and Considerations," Intellectual Property Today (Sept. 24, 2013)
  • "Patent Law: Biotechnology Update," American Bar Association (July 15, 2013)
  • "Protecting Self-Replicating Biotechnologies in View of Bowman v. Monsanto," Bloomberg BNA: Patent, Trademark & Copyright Journal (June 14, 2013)
  • "Myriad Ruling: Some Clarity, Some Uncertainty for Biotech," Law360 (June 14, 2013)

Highlighted Lectures

  • Panelist, “Advanced Licensing Agreements 2024,” Practising Law Institute (February 27, 2024)
  • Panelist, “Women in Financial Services Board Readiness,” (December 2023)
  • Panelist, “Advanced Licensing Agreements 2023,” Practising Law Institute (February 28, 2023)
  • Panelist, “Advanced Licensing Agreements 2022,” Practising Law Institute (March 1, 2022) 
  • Panelist, “Strategies to Mitigate NPE Risk,” Black In-House Counsel Network (April 27, 2021)
  • Panelist, “Advanced Licensing Agreements 2021,” Practising Law Institute (March 2, 2021) 
  • Panelist, “Perspectives on Diversity: Views on Trial Teams From the Bench, the Boardroom, and the Jury Box,” American Intellectual Property Law Association, (October 27, 2020) 
  • Panelist, “Enforcement of Trade Secrets: The Practical Realities,” AIPPI World Congress (October 2020) 
  • Panelist, “Advanced Licensing Agreements 2020,” Practising Law Institute (March 3, 2020) 
  • Panelist, “Keeping Good Brands From Going Bad: Recent Developments in Brand Protection,” National Bar Association's Convention & Exhibits Conference (July-August 2018) 
  • Speaker, “Digital Transformation: Powered by the Cloud Location,” National Bar Association Commercial Law Section's Corporate Counsel Conference (February 2018)

Court Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Third Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of Michigan
  • U.S. District Court for the Southern District of Texas
  • Registered Patent Attorney: U.S. Patent and Trademark Office 

Selected IP Litigations

Highlighted Matters

  • Cipla Ltd. v. Amgen (D. Del.): Represented Cipla in its patent litigation against Amgen in connection with Cipla's generic version of the prescription drug Sensipar. Achieved victory for Cipla and rejection of Amgen’s challenge
  • Alda Communications Trademark Litigation: Represented Alda Communications Training Company in its defeat of an international trademark application litigation challenge. Achieved victory for Alda Communications with the trademark petition from Aldi Inc. rejected
  • BASF Corp. v. SNF Holding Co. (D. Ga.): Represented SNF in the Federal Circuit’s ruling that the case had been filed in an improper venue and finding that a BASF patent was invalid and dismissed, in its entirety, a civil action for alleged patent infringement that BASF brought against SNF and several affiliates
  • 454 Life Sciences Corp. v. Ion Torrent Inc. et al., No. 1:15-cv-00595-JPS (D. Del.): Counsel for the patent owner in an action concerning a process called "emulsion polymerase chain reaction" for simultaneously amplifying multiple nucleic acids in a single reaction tube
  • Teva Pharmaceuticals USA v. Sandoz and Teva Pharmaceuticals USA v. Mylan Pharmaceuticals et al. (S.D.N.Y.): Represented Teva in consolidated Hatch-Waxman litigations concerning proposed generic equivalents to Teva's blockbuster multiple sclerosis drug Copaxone®
  • Wyeth v. Intervet (D. Del.): Represented Intervet in patent infringement litigation concerning patents related to porcine circovirus vaccine technology. Achieved a favorable claim construction ruling
  • Intervet v. Merial Ltd. et al. (D.D.C.): Represented Intervet in patent litigation resulting in a favorable ruling including a summary judgment of noninfringement
  • Pfizer v. Teva Pharmaceuticals USA et al. (D.N.J.): Represented Teva against a multibillion-dollar damages claim in a case relating to Pfizer's epilepsy drug Neurontin® (gabapentin). Achieved a favorable ruling including a summary judgment ruling
  • Institut Pasteur v. Simon (E.D. Pa.): Represented Institut Pasteur and the Centre National de la Recherche Scientifique in patent litigation resulting in a favorable summary judgment ruling regarding ownership of a portfolio of 13 patents related to DNA "molecular combing" technology. The ruling confirmed that the world-renowned French research institutions are the rightful owners of the entire portfolio of patents

Other Matters

  • Representation of Geller & Company on the sale of its multi-family office business to Corient, one of the fastest-growing national wealth advisors in the U.S.
  • Representation of Wipro on its $40 million acquisition of U.S.-based IT services consulting firm Applied Value Technologies
  • Representation of diversified biopharmaceutical company ANI Pharmaceuticals in its acquisition of global pharmaceutical company Alimera Sciences
  • Served as counsel in arbitrations representing Roche
  • Representation of Tao Group Hospitality in a deal to acquire Hakkasan Group, creating a premium hospitality powerhouse that includes a global portfolio of brands and properties
  • Representation of Turnitin, a leading provider of academic integrity and assessment solutions, in its acquisition of ExamSoft from private equity firm Spectrum Equity
  • Representation of Condé Nast in the sale of Golf Digest and Brides in two separate deals
  • Representation of Ascension Church in its planned sale of a Keith Haring mural described as the legendary street artist's “best kept secret”
Parody Defense and IP Enforcement in France
Client Advisories
View News Article
UPDATE - COVID-19 Impact on IP Owners and Litigants in France and the EU – Deadlines, Extensions and Operations of Courts and IP Offices - Update as of June 12, 2020
Client Advisories
View News Article
L’impact du Covid-19 sur les titulaires de droits de propriété intellectuelle et les parties a des litiges de propriété intellectuelle en France et dans l’UE - délais, prorogations et fonctionnement des tribunaux et offices de propriété intellectuelle
Client Advisories
View News Article
COVID-19 Impact on Intellectual Property Filings and Proceedings
Client Advisories
View News Article

News

Hughes Hubbard Advised Mercedes-Benz in Investment in Apptronik’s $403M Series A Funding Round
News & Events |
Deals & Matters
View News Article
Firm Reps Geller & Company on Sale of Multi-Family Office Business to Corient
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Reps Wipro in $40M Applied Value Technologies Acquisition
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Advises Aso O. Tavitian Foundation on Gift of 330+ Works of Art to the Clark Art Institute
Deals & Matters
View News Article
Patrice P. Jean, Ph.D. as President of the New York Intellectual Property Law Association Submits Comments to the United States Patent and Trademark Office
View News Article
Hughes Hubbard Leads ANI Pharmaceuticals’ Acquisition of Alimera Sciences
News & Events |
Deals & Matters
View News Article
Patrice Jean Named President of New York Intellectual Property Law Association
View News Article
HHR’s Women: Inspiring Inclusion
News & Events |
Inclusion
View News Article
Celebrating HHR’s Women
News & Events |
Inclusion
View News Article
In Law.com: Skilled in the Art: A Reply to Senators’ ‘Thicket’ Concerns
Articles & Press
View News Article
Litigation Wrap: First Quarter 2022
News & Events |
Awards |
People
View News Article
Hughes Hubbard Recognized by the Leadership Council on Legal Diversity (LCLD) With a 2021 Compass Award
News & Events |
Awards
View News Article
Five HHR Associates Selected for NYC Bar's 2021 Leadership Institute
News & Events |
Awards |
Inclusion |
People
View News Article
HHR Advises Tao Group Hospitality in Combination With Hakkasan Group
News & Events |
Deals & Matters
View News Article
Firm Leads Grab in Going Public Via De-SPACing Merger at $40B Pro-Forma Valuation
News & Events |
Deals & Matters
View News Article
HHR Advises on Greenbriar’s $400M Sale of Nordco
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Reps Spireon in Deal to Buy CalAmp’s Stolen Vehicle Solution
News & Events |
Deals & Matters
View News Article
Firm Guides ANI Pharmaceuticals in Deal to Buy Novitium Pharma
News & Events
View News Article
Litigation Wrap: Second Half 2020
News & Events |
Awards |
Pro Bono
View News Article
HHR Helps United Airlines Secure $7.491B CARES Act Loan
News & Events
View News Article
Firm Advises Platinum Equity in Nesco’s $1.48B Deal
News & Events |
Deals & Matters
View News Article
Firm Reps Turnitin in Deal to Buy ExamSoft
News & Events |
Deals & Matters
View News Article
Firm Assists Infosys in Deal to Buy Blue Acorn iCi
News & Events |
Deals & Matters
View News Article
Patrice Jean Named a 2020 ‘Woman Worth Watching’ by Profiles in Diversity Journal
News & Events |
Inclusion
View News Article
Firm Lays Groundwork for Auction of Keith Haring Mural
News & Events |
Deals & Matters
View News Article
Litigation Wrap: Third Quarter 2019
News & Events |
Awards |
Deals & Matters
View News Article
HHR Keeps Up Strong Showing in AmLaw, Law360 Diversity Surveys
Articles & Press |
Awards |
Inclusion
View News Article
Litigation Wrap: Second Quarter 2019
News & Events |
Awards |
Deals & Matters
View News Article
Firm Assists Condé Nast in Sale of Golf Digest and Brides
News & Events |
Deals & Matters
View News Article
In Law360's Weekly Verdict: Firm Named Legal Lions
Articles & Press
View News Article
In Law360: One Sentence Ends Amgen Blockbuster's Reign, Judge Says
Articles & Press |
Deals & Matters
View News Article
Litigation Wrap: First Quarter 2019
News & Events |
Awards |
Deals & Matters |
Pro Bono
View News Article
Hughes Hubbard Reps Pure Power Technologies in Sale to Stanadyne
News & Events |
Deals & Matters
View News Article
Celebrating International Women's Day
News & Events |
People
View News Article
Litigation Wrap: Fourth Quarter 2018
News & Events |
Awards |
Deals & Matters |
People
View News Article
Litigation Wrap: Third Quarter 2018
News & Events |
Awards |
Deals & Matters |
Event Recap |
Pro Bono
View News Article
Hughes Hubbard Ranked Among Law360's Best Firms for Minority Attorneys
News & Events |
Awards |
Inclusion
View News Article
Patrice Jean Awarded 'Private Practitioner of the Year' by the Metropolitan Black Bar Association
News & Events |
People
View News Article
Hughes Hubbard Welcomes Next Class of Ronald Brown Law School Prep Program
News & Events |
Inclusion
View News Article
Hughes Hubbard Helps Form Nonprofit for Young Artists
News & Events |
Pro Bono
View News Article
Intellectual Property Team Named Among Law360 Practice Groups of the Year
Articles & Press |
Awards
View News Article
Litigation Wrap: Fourth Quarter 2017
News & Events |
Awards |
Deals & Matters |
People
View News Article
Firm Wins Venue Transfer Order in SNF Patent Case
News & Events |
Deals & Matters
View News Article
Firm Helps Alan Alda Achieve His Dream of Making Science More Accessible
News & Events |
Deals & Matters
View News Article
​Firm Advises MSG in Purchase of Majority Stake in Tao Group
News & Events
View News Article
Estate Planning For the Digital Afterlife
Articles & Press
View News Article
Hughes Hubbard Receives Diversity Award From Eaton
News & Events |
Inclusion
View News Article
Increasing Diversity in the Legal Profession
News & Events |
Inclusion |
Event Recap
View News Article
Hughes Hubbard Sponsors Council of Urban Professionals Gala 2016
News & Events |
Inclusion
View News Article
Hughes Hubbard Welcomes Patrice P. Jean as Partner in the Firm’s Intellectual Property Practice
News & Events |
People
View News Article
Education
  • Columbia University, School of Law, J.D., 2002, Editor-in-Chief, Columbia Science & Technology Law Review
  • Princeton University, Ph.D., Molecular Biology, 1999
  • Princeton University, M.A., Molecular Biology, 1996
  • Xavier University of Louisiana, B.S., 1993
Bar Admissions
  • District of Columbia
  • New York
Areas of Focus
Digital Assets and Blockchain
Environmental, Social & Governance (ESG)
Intellectual Property
Life Sciences
Litigation
Media and Entertainment
Product Liability
Regulatory Compliance

Hughes Hubbard & Reed LLP

Copyright 2025


Legal Notices Attorney Advertising Sitemap
𝕏
  • Locations
  • New York City
  • Kansas City
  • Los Angeles
  • Miami
  • Paris
  • Rio de Janeiro*
  • Tokyo
  • Washington, DC

*In cooperation with Saud Advogados

Privacy Policies and Notices

Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Inclusion Pro Bono
Contact
𝕏